FDA Inspection 610604 — Zhejiang Hisoar Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Pharmaceutical Co. Ltd. on August 29, 2009 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 29, 2009
- Fiscal Year
- 2009
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Taizhou (China)